Protagonist Therapeutics' IPO

Protagonist Therapeutics raised a round of funding on August 11, 2016. Investors include Public.

Protagonist Therapeutics is a biotechnology company pursuing the discovery and development of target oral peptides as well differentiated alternatives to antibodies, and also as new chemical entities …

Articles about Protagonist Therapeutics' IPO: